Equity Profile

CORZ

Core Scientific, Inc.

Information TechnologyApplication Software$8.2B

May6Wed

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

Core Scientific, Inc. Misses on EPS, Stock Up 11.0%

Metric	Actual	Expected	Surprise
EPS	$-1.06	N/A	-6966.67%
Revenue	—	N/A	—

management commentary, guidance changes, and full analysis available with Pro.

Core Scientific, Inc. Misses on EPS, Stock Up 11.0%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$-1.06	N/A	-6966.67%
Revenue	—	N/A	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

What It Means

Core Scientific reported a significant loss in EPS, missing expectations by a wide margin. Despite this, the stock rose by 11%, indicating that investors may be reacting positively to other factors not captured in the earnings metrics. The lack of revenue data and management commentary leaves some uncertainty about the company's current performance and future outlook.

Company Snapshot

Core Scientific Inc (CORZ) operates in the information technology sector, focusing on application software. The company plays a significant role in the growing fields of cloud computing and artificial intelligence, which are increasingly vital for businesses looking to enhance efficiency and innovation.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help investors gauge the company's financial health this quarter.

N/A

Revenue Growth

Understanding revenue trends is crucial for assessing the company's market performance and growth potential.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-2100.11%

Avg Stock Reaction

+3.57%

Last Quarter Recap

In the last quarter, Core Scientific reported an EPS of $0.42, significantly beating estimates. However, the stock experienced a slight decline the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Management committed to focusing on improving operational efficiency.
They highlighted plans to enhance software offerings to capture more market share.
The company expressed intentions to explore new strategic partnerships.

Expectations

Wall Street Expectations

Overall, expectations for Core Scientific's upcoming earnings are mixed due to the lack of analyst estimates and guidance. Investors are keen to see if the company can maintain its recent momentum.

Bull Case

If Core Scientific can report strong revenue growth and improved margins, it could signal a robust recovery and attract more investor interest.

Bear Case

Conversely, if the company fails to meet profitability expectations or shows signs of operational challenges, it could lead to a significant sell-off.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter and how does it compare to previous quarters?

EPS will be a critical indicator of the company's profitability and could significantly influence investor sentiment.

What specific revenue growth targets has management set for this quarter?

Revenue growth is essential for assessing the company's performance and future prospects, especially in a competitive market.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Core Scientific's ability to leverage its software innovations for revenue growth this quarter.

Supporting Evidence

Recent operational improvements could lead to better-than-expected margins.

The company's strategic partnerships may yield unexpected revenue streams.

Historical data shows that the company has a strong track record of beating EPS estimates.

Key Risk

If revenue growth exceeds 20%, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results are pivotal as they will indicate whether the company can sustain its growth trajectory amidst market challenges.

Bull Confirmed If

A revenue growth rate of at least 15% year-over-year would confirm the bull case.

Bear Confirmed If

If EPS falls below $0.10, it would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±N/A

Historical Avg

±4.5%

Pricing rich

There is currently no options market data available to gauge investor sentiment.

Options are pricing ±11.5% while CORZ has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.6%

30d HV

57.3%

Calls (7.2M)P/C Ratio: 0.22Puts (4.1M)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$384,199.24

20,000 sh

1 insider

Net

$384,199.24

Net selling

Most Active Insiders· 3 open-market trades

See remarksDUCHENE TODD M
$384,199.24
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Core Scientific beats expectations, history suggests the stock could rise by around 1.33%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await clearer guidance.

Miss

Should the company miss earnings expectations, history indicates a potential decline of approximately 4.62%, leading to increased investor caution.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new software product launches and their expected impact on revenue.
2Management's commentary on operational efficiency improvements.
3Insights into customer acquisition strategies and market expansion plans.
4Details on any strategic partnerships that could enhance growth.
5Guidance on future earnings expectations and market conditions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will help investors gauge the company's financial health this quarter.

N/A

Revenue Growth

Understanding revenue trends is crucial for assessing the company's market performance and growth potential.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-2100.11%

Avg Stock Reaction

+3.57%

Last Quarter Recap

In the last quarter, Core Scientific reported an EPS of $0.42, significantly beating estimates. However, the stock experienced a slight decline the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Management committed to focusing on improving operational efficiency.
They highlighted plans to enhance software offerings to capture more market share.
The company expressed intentions to explore new strategic partnerships.

Expectations

Wall Street Expectations

Overall, expectations for Core Scientific's upcoming earnings are mixed due to the lack of analyst estimates and guidance. Investors are keen to see if the company can maintain its recent momentum.

Bull Case

If Core Scientific can report strong revenue growth and improved margins, it could signal a robust recovery and attract more investor interest.

Bear Case

Conversely, if the company fails to meet profitability expectations or shows signs of operational challenges, it could lead to a significant sell-off.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected EPS for this quarter and how does it compare to previous quarters?

EPS will be a critical indicator of the company's profitability and could significantly influence investor sentiment.

What specific revenue growth targets has management set for this quarter?

Revenue growth is essential for assessing the company's performance and future prospects, especially in a competitive market.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating Core Scientific's ability to leverage its software innovations for revenue growth this quarter.

Supporting Evidence

Recent operational improvements could lead to better-than-expected margins.

The company's strategic partnerships may yield unexpected revenue streams.

Historical data shows that the company has a strong track record of beating EPS estimates.

Key Risk

If revenue growth exceeds 20%, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results are pivotal as they will indicate whether the company can sustain its growth trajectory amidst market challenges.

Bull Confirmed If

A revenue growth rate of at least 15% year-over-year would confirm the bull case.

Bear Confirmed If

If EPS falls below $0.10, it would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±N/A

Historical Avg

±4.5%

Pricing rich

There is currently no options market data available to gauge investor sentiment.

Options are pricing ±11.5% while CORZ has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.6%

30d HV

57.3%

Calls (7.2M)P/C Ratio: 0.22Puts (4.1M)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$384,199.24

20,000 sh

1 insider

Net

$384,199.24

Net selling

Most Active Insiders· 3 open-market trades

See remarksDUCHENE TODD M
$384,199.24
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Core Scientific beats expectations, history suggests the stock could rise by around 1.33%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await clearer guidance.

Miss

Should the company miss earnings expectations, history indicates a potential decline of approximately 4.62%, leading to increased investor caution.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new software product launches and their expected impact on revenue.
2Management's commentary on operational efficiency improvements.
3Insights into customer acquisition strategies and market expansion plans.
4Details on any strategic partnerships that could enhance growth.
5Guidance on future earnings expectations and market conditions.